Sector valuations Charles River Laboratories International, Inc. CBOE
Stocks
CRL
US1598641074
Biotechnology & Medical Research
|
Market Closed -
CBOE
03:59:50 22/08/2026 HKT
|
5-day change | 1st Jan Change | ||
| 295.33 USD | +1.32% |
|
+3.67% | +45.99% |
| 08-21 | Charles River Laboratories International Insider Sold Shares Worth $599,711, According to a Recent SEC Filing | MT |
| 08-20 | Charles River, Medigen Partner on Multivalent Enterovirus Vaccine | MT |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | 34.4x | 4.58x | 1.32x | 6.13x | 18.24x | 25.65x | 0.93% | 51.22B | |
| -21.71x | 22.98x | -0.34x | 301.09x | -22.35x | -21.33x | -.--% | 45.38B | |
| 32.97x | 6.02x | -34.54x | 3.21x | 13.87x | 20.96x | -.--% | 42.15B | |
| 48.36x | 8.19x | 0.24x | 5.61x | 30.68x | 35.45x | -.--% | 41.97B | |
| 29.48x | 2.4x | 0.61x | 8.52x | 21.54x | 25.56x | 0.39% | 31.95B | |
| 34.84x | 25x | 2.31x | 5.71x | 25.97x | 27.17x | -.--% | 17.1B | |
| 24.28x | 2.72x | 0.7x | 2.11x | 9.12x | 14.12x | 1.11% | 14.76B | |
| 77.97x | 4.62x | -0.34x | 4.1x | 15.89x | 19.52x | -.--% | 13.91B | |
| 29.52x | 1.4x | 0.29x | 1.94x | 11.9x | 13.56x | -.--% | 13.45B | |
| 46.3x | 5.4x | 2.72x | 5.47x | 22.71x | 34.07x | 0.48% | 12.73B | |
| -46.72x | 24.45x | -39.93x | 7.86x | 192.48x | -2561.2x | -.--% | 12.03B | |
| 60.74x | 5.19x | 0.38x | 9.26x | 26.32x | 28.75x | 0.44% | 11.26B | |
| -28.25x | 8.32x | 1.06x | 110.41x | -31.43x | -54.69x | -.--% | 10.95B | |
| -26.24x | 9.06x | -8.59x | 10981.81x | -21.69x | -21.36x | -.--% | 10.18B | |
| -28.9x | 9.28x | -2.76x | - | -25.52x | -25.58x | -.--% | 10.16B | |
| -31.55x | 9.12x | -7.21x | 82.88x | -21.07x | -20.51x | -.--% | 10.1B | |
| -16.14x | 680.25x | -0.3x | 10.58x | -16.96x | -16.36x | -.--% | 9.76B | |
| 32.79x | - | -0.1x | 17.13x | 31.56x | 30.81x | -.--% | 9.75B | |
| Average | 14.01x | 48.76x | -4.69x | 680.23x | 15.63x | -135.86x | 0.19% | 20.49B | |
| Weighted average by Cap. | 19.68x | 27.67x | -5.28x | 360.25x | 14.76x | -71.92x | 0.24% |
Select your edition
All financial news and data tailored to specific country editions
